Sita Duo Tablets 10/100 mg
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Intro Biopharma Co., Ltd.
MFDS item code 202300252 · Approved 2023.01.13
Improvement in blood sugar control for type 2 diabetes
This medication is used in addition to diet and exercise to help patients with type 2 diabetes manage their blood sugar. It is designed to effectively manage blood glucose levels through the combined use of sitagliptin and dapagliflozin. Therefore, this medication is used to improve blood sugar levels and assist in the management of diabetes.
This medication may be administered as one tablet once daily for patients receiving sitagliptin 100 mg and dapagliflozin 10 mg, regardless of meals. The tablet must be swallowed whole.
This medication contains sitagliptin and dapagliflozin. Firstly, serious allergic reactions may occur during the use of this medication. If symptoms such as skin rash, difficulty breathing, or swelling of the face or neck occur, stop taking the medicine immediately and consult a doctor. Additionally, cases of acute pancreatitis, which is inflammation of the pancreas, have been reported, so if symptoms such as abdominal pain, nausea, or vomiting appear, inform medical personnel immediately. This medication is not recommended for patients with type 1 diabetes or those receiving renal dialysis. Patients with poor kidney function need dose adjustments, and particular caution is required for patients with reduced fluid volume or low blood pressure. Dapagliflozin may increase the risk of decreased fluid volume, low blood pressure, urinary tract infections, and genital infections. If these symptoms occur, consult medical personnel immediately. Also, serious metabolic abnormalities known as diabetic ketoacidosis may occur, so if symptoms such as nausea, vomiting, abdominal pain, or difficulty breathing arise, visit a hospital immediately. Taking this medication in combination with blood glucose-lowering agents such as insulin or sulfonylureas may increase the risk of hypoglycemia; hence, be alert for symptoms of hypoglycemia and adjust the dose of blood glucose-lowering agents if necessary. Elderly patients or those with impaired liver function should consult a doctor before taking this medication, and regular kidney function monitoring is advised. This medication is not recommended for use during pregnancy or lactation, so always consult a doctor before taking it. Finally, while taking this medication, be cautious as there may be risks related to hypoglycemia when driving or operating machinery. This medication should be taken strictly according to the doctor's prescription and instructions, and any unusual symptoms should be reported to medical personnel immediately.
Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, paleness, severe allergic reactions, severe rash with fever, blisters, skin peeling, pain in mucous membranes of mouth/eyes, severe skin adverse reactions, difficulty breathing or asthma attacks, cough and fever with respiratory symptoms, breathing difficulties, jaundice (yellowing of the skin or eyes), profound lethargy, liver abnormalities (jaundice), sudden.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, ideally at room temperature between 1 to 30 degrees Celsius. This is to maintain the medication's efficacy and prevent degradation.
Beige oval film-coated tablets
PTP - 30 tablets/PTP [(10 tablets/PTP * 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Intro Biopharma Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Daewoo Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
IYON Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Kujoo Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.